Form 8-K - Current report:
SEC Accession No. 0001193125-25-064792
Filing Date
2025-03-27
Accepted
2025-03-27 09:15:42
Documents
13
Period of Report
2025-03-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d937220d8k.htm   iXBRL 8-K 26157
  Complete submission text file 0001193125-25-064792.txt   151777

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA krro-20250327.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE krro-20250327_lab.xml EX-101.LAB 18757
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krro-20250327_pre.xml EX-101.PRE 11704
16 EXTRACTED XBRL INSTANCE DOCUMENT d937220d8k_htm.xml XML 3799
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 25775656
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)